comparemela.com

Latest Breaking News On - Pharmabcine inc - Page 9 : comparemela.com

PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference

PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Daejeon
Taejon-gwangyoksi
South-korea
Paul-kim
Jin-san-yoo
Hc-wainwright-co
Linkedin
Business-development-team
Sagient-research-systems
Ir-pr-team
Pharmabcine-inc
Youtube

PharmAbcine to Present at AACR Annual Meeting 2021

PharmAbcine to Present at AACR Annual Meeting 2021 News provided by Share this article Share this article DAEJEON, South Korea, March 11, 2021 /PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today an e-poster presentation featuring nonclinical data of PMC-309 at American Association for Cancer Research (AACR) Annual Meeting. The meeting will take place virtually over April 10-15 and May 17-21 2021.    Presentation Details Title: PMC309, a highly selective anti-VISTA antibody enhances T cell activation through blocking the interaction of T cells and myeloid derived suppressor cells (MDSC) Session category/title: Immunology/Immune Checkpoints

Daejeon
Taejon-gwangyoksi
South-korea
United-states
American
Jin-san-yoo
Pharmabcine-inc
American-association-for-cancer-research
Youtube
Linkedin
Prnewswire-pharmabcine-inc
American-association

PharmAbcine announces a research collaboration with LegoChem Biosciences

PharmAbcine announces a research collaboration with LegoChem Biosciences News provided by Share this article Share this article DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/  PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Biosciences Inc. (KOSDAQ: 141080ks), a biopharmaceutical company focusing on the research and development of ADCs (Antibody-Drug Conjugates) in South Korea. Under the agreement, PharmAbcine will provide PMC-403, a preclinical pipeline, to LCB so LCB can conduct a combination research using PMC-403 and LCB s proprietary ADC. This preclinical study will allow both parties to evaluate the efficacy of the combination therapy in solid tumors.

Daejeon
Taejon-gwangyoksi
South-korea
Legochem-biosciences
Jin-san-yoo
Pharmabcine-inc
Legochem-biosciences-inc
Antibody-drug-conjugates
Age-related-macular-degeneration
Chem-biosciences
Pharmabcine
தெற்கு-கொரியா

Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Germany
Japan
United-states
United-kingdom
Boston
Massachusetts
Italy
France
Spain
Shruti-thakur
Los-angeles
Delveinsight-osteosarcoma
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.